Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

European Wax Center NASDAQ EWCZ Earnings Forecast and Historical Performance Analysis

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
Finance_ Stock Charts (2)
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

The latest earnings forecast for European Wax Center (NASDAQ: EWCZ) is as follows:

Earnings Per Share (EPS) Prediction: Analysts predict that European Wax Center will reveal an EPS of $0.07.

Looking back at past performance, in the previous quarter, the company exceeded EPS expectations by $0.03, leading to a 5.56% decrease in share price the following day. Here is a recap of historical performance:

Q3 2023: EPS Prediction 0.09, EPS Actual 0.12, Price Change -6.0%
Q2 2023: EPS Prediction 0.11, EPS Actual 0.11, Price Change -1.0%
Q1 2023: EPS Prediction 0.04, EPS Actual 0.05, Price Change -1.0%
Q4 2022: EPS Prediction 0.08, EPS Actual 1.08, Price Change -4.0%

Regarding stock performance, European Wax Center’s shares were valued at $13.48 as of March 04, showing a negative return of 28.38% over the past 52 weeks.

Investors will be eagerly awaiting European Wax Center’s earnings report, hoping for not only an earnings beat but also positive guidance for the upcoming quarter. This guidance often plays a crucial role in influencing stock prices.

EWCZ Stock Price Plummets on March 5, 2024: What Investors Need to Know

On March 5, 2024, EWCZ stock experienced a significant drop in its price performance. The stock opened at $13.34, which was $0.14 lower than its previous close. Throughout the trading day, the price of EWCZ shares continued to decrease, ultimately dropping by $0.43, or 3.19%, by the time the market closed.

The drop in EWCZ’s stock price on March 5th may be concerning to investors, as it suggests that there may be underlying issues affecting the company’s performance. It is important for investors to conduct further research into EWCZ’s financial health, market position, and any recent news or events that may have influenced the stock’s price movement.

Overall, the performance of EWCZ stock on March 5, 2024, highlights the volatility and uncertainty that can be present in the stock market. Investors should carefully monitor the performance of EWCZ and consider seeking advice from financial professionals before making any investment decisions.

EWCZ Stock Analysis: Mixed Performances on March 5, 2024

On March 5, 2024, EWCZ stock experienced mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was $207.35 million, showing a 16.05% increase compared to the previous year. However, the total revenue for the third quarter was $55.72 million, indicating a 5.71% decrease from the previous quarter.

In terms of net income, EWCZ reported a net income of $7.56 million for the past year, marking a significant 321.46% increase from the previous year. However, the net income for the third quarter was $2.99 million, reflecting a 26.56% decrease from the previous quarter.

Earnings per share (EPS) also showed a similar trend, with an EPS of $0.19 for the past year, representing a 304.0% increase from the previous year. However, the EPS for the third quarter was $0.06, indicating a 26.64% decrease from the previous quarter.

Overall, EWCZ stock performances on March 5, 2024, were influenced by the mixed financial results. While there were significant increases in net income and EPS compared to the previous year, the decreases in total revenue and net income from the previous quarter may have impacted investor sentiment.

Tags: EWCZ
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances (2)

Capitalizing on Niche Opportunities The Success of 1847 Holdings LLC in the Private Equity Market

Automotive Trading online

Title Arson Attack Halts Production at Tesla Factory in Berlin

Analysts Offer Varied Predictions for BridgeBio Pharmas Stock Future

Recommended

Biotechnology Stock Exchange

Analysts Bullish on Dynatrace with Price Targets on the Rise

2 years ago
The Trade Desk Stock

The Trade Desk Faces Mounting Pressure as Amazon Strikes Netflix Deal

5 months ago

Analyst Reaffirms Buy Rating on International Seaways with 66 Price Target

2 years ago
Biotechnology Stock Bull Market

KeyBanc Analyst Raises Price Target and Maintains Overweight Rating on Repligen NASDAQ RGEN

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Trending

Puma Biotechnology Stock
Earnings

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

by Jackson Burston
February 8, 2026
0

Investor attention is now firmly fixed on February 26, 2026, as Puma Biotechnology prepares to release its...

Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure
  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test
  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com